Prostate Cancer: From Molecular Basis to Clinical Therapy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 214
Special Issue Editors
Interests: prostate cancer; androgen receptor; castration resistance; small peptide drug; metabolomics
Special Issue Information
Dear Colleagues,
Prostate cancer is still a great challenge worldwide. Fundamental advances have been made in this cancer in recent years. New molecular events, new imaging technologies, novel drugs, and new diagnostic and treatment strategies are emerging in this field. This Special Issue of Biomedicines focuses on recent advances in the understanding of the molecular events underlying prostate cancer, imaging of prostate cancer, prostate biopsy decisions, and the clinical treatment of prostate cancer. Treatment resistance, neuroendocrinal progression, targeted therapy, and immunotherapy are also discussed. The goal of this Special Issue is to stimulate research and clinical interest in this exciting field. In particular, we hope this Special Issue will improve our understanding of this malignant disease, and encourage physicians, urologists, and medical oncologists to share clinical decisions and improve treatment outcomes in patients with prostate cancer.
Prof. Dr. Benyi Li
Dr. Qi Ma
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- treatment resistance
- neuroendocrinal progression
- small peptide
- targeted therapy
- immunotherapy
- androgen receptor
- PROTAC
- immunogenic cell death
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
